Sangui Biotech International Inc (SGBI)
0.0015
0.00 (0.00%)
USD |
OTCM |
Jun 28, 16:00
Sangui Biotech International Debt to Equity Ratio
Debt to Equity Ratio Chart
Historical Debt to Equity Ratio Data
Date | Value |
---|---|
March 31, 2023 | -2.221 |
December 31, 2022 | -2.476 |
September 30, 2022 | -3.443 |
June 30, 2022 | -3.211 |
March 31, 2022 | -3.413 |
December 31, 2021 | -3.073 |
September 30, 2021 | -3.119 |
June 30, 2021 | -3.366 |
March 31, 2021 | -3.198 |
December 31, 2020 | -3.176 |
September 30, 2020 | -4.294 |
June 30, 2020 | -7.462 |
March 31, 2020 | -28.93 |
December 31, 2019 | -268.91 |
September 30, 2019 | 8.849 |
June 30, 2019 | 9.722 |
March 31, 2019 | 2.433 |
December 31, 2018 | 1.388 |
September 30, 2018 | 1.902 |
June 30, 2018 | 0.9013 |
March 31, 2018 | 1.199 |
December 31, 2017 | 0.6446 |
September 30, 2017 | 0.489 |
June 30, 2017 | 0.4406 |
March 31, 2017 | 0.4609 |
Date | Value |
---|---|
December 31, 2016 | 0.3885 |
September 30, 2016 | 0.3875 |
June 30, 2016 | 0.4384 |
March 31, 2016 | 0.4106 |
December 31, 2015 | 0.6043 |
September 30, 2015 | 1.607 |
June 30, 2015 | 0.8829 |
March 31, 2015 | 0.3115 |
December 31, 2014 | 0.00 |
September 30, 2014 | 0.00 |
June 30, 2014 | 0.00 |
March 31, 2014 | 0.00 |
December 31, 2013 | 0.00 |
September 30, 2013 | 0.00 |
June 30, 2013 | 0.0294 |
March 31, 2013 | 0.00 |
December 31, 2012 | 0.00 |
September 30, 2012 | 0.00 |
June 30, 2012 | 0.00 |
March 31, 2012 | 0.00 |
December 31, 2011 | 0.00 |
September 30, 2011 | 0.00 |
June 30, 2011 | 0.00 |
March 31, 2011 | 0.00 |
December 31, 2010 | 0.00 |
Debt to Equity Ratio Definition
The debt to equity ratio measures the (Long Term Debt + Current Portion of Long Term Debt) / Total Shareholders' Equity. This metric is useful when analyzing the health of a company's balance sheet.
Debt to Equity Ratio Range, Past 5 Years
-268.91
Minimum
Dec 2019
8.849
Maximum
Sep 2019
-22.10
Average
-3.211
Median
Jun 2022
Debt to Equity Ratio Benchmarks
Debt to Equity Ratio Related Metrics
Total Assets (Quarterly) | 0.0891M |
Total Liabilities (Quarterly) | 1.099M |
Shareholders Equity (Quarterly) | -0.3543M |